Developer docs
API playgroundTry for free, no card

Search company profiles

cureVision

Full company profile

uuid0000czn

Namestring
cureVision
Legal namestring
cureVision GmbH
Websiteurl
curevision.de
Company typeenum
Private
Founded yearint
2021
Descriptiontext

cureVision GmbH is a German health technology company founded in 2021 in Munich and Potsdam that develops an AI-driven, MDR-certified medical device system for chronic wound documentation and analysis. The core product, the cv.MESH device, combines multiple sensors — RGB camera, depth sensor, thermal imaging, and multispectral fluorescence imaging — to perform contactless, automated 3D wound measurement and tissue composition analysis in approximately two minutes per documentation, compared with roughly 20 minutes using conventional paper-ruler methods. The platform includes three subscription tiers (ESSENTIAL, PROFESSIONAL, PREMIUM), optional modules (BacteriaScan for bacterial contamination detection, ThermoScan for thermal abnormality detection, prescription recommendation), a web-based management platform (cureVision Web), and a hospital integration layer (cureVision Connect) supporting FHIR, HL7, GDT, and REST protocols.

The company sells primarily to hospitals and clinics, nursing homes and outpatient care services, and home care and wound management providers in the DACH region, with a stated go-to-market that combines direct enterprise sales, inside sales/demo booking, channel partners (notably BioLab Holdings for U.S. market entry announced in September 2025), event participation at wound fairs, and content marketing through whitepapers and case studies. Named customers include Klinikum Nürnberg, Spörer AG, Bürgerspital Landau, AGM Müller, Wundversorgung Otto, PROLIFE, PHV, Pflegedienst Engel vonne Ruhr, Sozialstation Herbert Hildebrand, Pflegeteam Geisel, and Noracare. The company is GDPR-compliant with data stored exclusively on German servers, has been recognized with multiple innovation awards (Innovationspreis Bayern 2024, Health-i Award 2023, Digitaler Gesundheitspreis 2023, Eugen Münch Preis 2023, German Startup and Digitalization Prize 2022), and has raised approximately $2.9M+ across funding rounds from 2021 through 2024 with a strategic investment from BioLab Holdings in 2025 to support U.S. market expansion, FDA clearance pursuit, and commercialization.

Short descriptiontext

cureVision develops an AI-driven, MDR-certified 3D wound analysis medical device (cv.MESH) that automates chronic wound documentation for hospitals, nursing homes, and home care providers in Germany, with active U.S. expansion via BioLab Holdings.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMunich, Germany
HQ citystring
Munich
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
AI wound analysis, 3D wound measurement, wound documentation software, medical imaging AI, chronic wound care
Industry5 codes
PRIMARYHLAKACAN
Wound Care & Ulcer Management
SECONDARYHLAKAGAK
Wound Care & Diabetic Foot Infection
SECONDARYHLADAFAH
Home-Based Wound Care & Ostomy Nursing
Healthcare & Life Sciences/Elder Care & Long-Term Care/Home Health Care Services (Skilled)
SECONDARYHLADADAJ
Complex Wound Care SNFs
Healthcare & Life Sciences/Elder Care & Long-Term Care/Skilled Nursing Facilities (SNF) & Nursing Homes
SECONDARYHLAHACAK
Continuous Temperature & Fever Monitoring (Wearable Thermometry)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
NAICS code3 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Surgical and Medical Instrument Manufacturing339112
  • Surgical Appliance and Supplies Manufacturing339113
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Medical Imaging and Wound Care Software
Social media profiles1 record
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model2 records
1Software Subscription (Tiered)
TypeSubscription Recurring
Description

Three-tier subscription model: ESSENTIAL (up to 10 patients), PROFESSIONAL (unlimited patients with telephone support), and PREMIUM (large facilities with advanced features). All tiers include base wound analysis features with optional add-ons like BacteriaScan and prescription recommendation. Plus one-time setup fee.

curevision.de
2Hardware Device Sales
TypeHardware Sales
Description

Sale of cv.MESH hardware device - MDR-certified wound analysis device. Hardware is required to use the software platform. Sold as part of initial system setup.

curevision.de
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations
Pricing details3 tiers
1Up to 10 patients, essential wound documentation features
ModelSubscriptionBilling cadenceMonthly
Notes

ESSENTIAL tier includes: patient management, contactless documentation, 3D wound analysis, tissue analysis, digital photo documentation, automatic wound report generation, MDR-certified device. Optional: mobile data connection with built-in SIM card (additional fees).

curevision.de
2Unlimited patients, telephone support, secure report sharing, editing from any device
ModelSubscriptionBilling cadenceMonthly
Notes

PROFESSIONAL tier includes everything in ESSENTIAL plus: unlimited patient capacity, telephone support, secure wound report exchange, editing from any device. Optional add-ons: BacteriaScan and product suggestions, Prescription recommendation module.

curevision.de
3Large teams, full customization, internal quality control, location management, FHIR integration
ModelSubscriptionBilling cadenceMonthly
Notes

PREMIUM tier includes everything in PROFESSIONAL plus: personalized wound assessment (edit/delete/add options), internal quality control with role assignment and approval workflows, multi-location management, FHIR integration (by individual agreement, additional charge).

curevision.de
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 4 records shown
1BacteriaScan
Description

AI-powered bacterial contamination detection feature using fluorescence imaging to identify areas with increased bacterial load in wounds

curevision.de
+3 more records
Core offering1 text field

cureVision develops and sells an MDR-certified AI-driven 3D wound analysis system consisting of the cv.MESH handheld multi-sensor hardware device (RGB camera, depth sensor, thermal camera, multispectral imaging) and cloud-based software for fully automated wound measurement, tissue analysis, bacterial detection, and digital wound documentation. The solution is offered to hospitals, nursing homes, and home care providers under tiered monthly subscriptions with optional add-on modules (BacteriaScan, ThermoScan, prescription recommendation) and a one-time setup fee.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 90% time reduction in wound documentation (from 20 minutes to 2 minutes)
+3 more records
Product overview1 text field

cureVision offers a unified medical device ecosystem for AI-driven wound analysis and digital documentation, centered on the cureVision® System (cv.MESH) — an MDR-approved handheld device that performs fully automated 3D wound assessment combining RGB imaging, infrared thermography (ThermoScan), and multispectral bacterial fluorescence detection (BacteriaScan). The core system is augmented by two cloud/web components: cureVision® Web provides a PC-based platform for centralized wound report management, editing, approval workflows, and multi-location administration; and cureVision Connect enables KIS/HIS integration via FHIR or GDT protocols. Three subscription tiers (ESSENTIAL, PROFESSIONAL, PREMIUM) provide escalating access to features including the optional Prescription Recommendation module. The company also recently announced a strategic partnership with BioLab Holdings to enter the U.S. market.

Product and service5 records
1cureVision® System (cv.MESH)
CategoryMedical Imaging Device / Core Hardware
Description

The primary MDR-approved medical device for automated 3D wound analysis. Combines multiple sensors (RGB camera, depth sensor, thermal camera, multispectral imaging) with AI to analyze wound size, depth, tissue types, temperature, and bacterial load at the push of a button. Disinfectable, fall-proof hardware that performs contact-free analysis 10x faster than manual methods, reducing documentation time from ~20 minutes to ~2 minutes. Sold to hospitals, nursing homes, and home care providers as part of the initial system setup.

2cureVision® BacteriaScan
CategoryAdd-on Diagnostic Module
Description

Multispectral imaging module that detects bacterial contamination in and around wounds using violet LED-induced fluorescence to highlight porphyrin and pyoverdin metabolites. Visualizes bacterial load in red or green fluorescence, enabling early infection detection, targeted swab collection, and optimized wound cleansing. Detects bacterial loads from approximately 10^4 CFU/g and works in daylight conditions without full room darkening. Available as an add-on on the PROFESSIONAL and PREMIUM tiers.

3cureVision® ThermoScan
CategoryAdd-on Diagnostic Module
Description

Infrared thermography module integrated into the cv.MESH device for early detection of abnormal thermal patterns indicating inflammation (positive temperature gradient), ischemia, or necrosis (negative temperature gradient). Generates thermal images within seconds to track wound healing progress and predict pressure ulcer development before tissue damage becomes visible on intact skin.

4cureVision® Web
CategoryWeb Software Platform
Description

Web-based platform for managing wound reports, editing documentation on PC, and administering the cureVision system. Enables centralized patient data management, digital patient file maintenance, dashboard views of wound healing progress, calendar tracking for due documentation, role-based approval workflows for quality control, multi-location management, customizable assessment questionnaires, and secure sharing of wound reports with healthcare providers.

5cureVision Connect
CategoryIntegration Platform / Interoperability Module
Description

Interface module enabling integration of the cureVision system into hospital information systems (KIS/HIS) via FHIR, HL7, REST, or GDT (Geräte-Datenträger-Transfer) protocols. Allows wound reports to be transferred directly into patient files automatically. Existing interfaces available with acriba and HalloAlberta industry software. Available on the PREMIUM tier for an additional charge, with FHIR integration priced by individual agreement.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-09-04
Description

Strategic investment and partnership to introduce cureVision's AI-driven wound assessment technology in the U.S. market. BioLab provides distribution network, regulatory approval support, reimbursement expertise, and commercialization capabilities. Aimed at accelerating cureVision's FDA approval and market entry in the United States.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Supported cureVision from early stages. Recognized company's potential and provided support through startup incubation program. CureVision won multiple awards through SCE connections including Health-i-Award 2023.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

European Institute of Innovation and Technology Health program recognized cureVision's potential and provided support. Part of innovation ecosystem helping healthcare startups scale.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Healthcare innovation network that recognized cureVision's potential and provided backing. Supports company on mission to improve treatment and quality of life for chronic wound patients.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Technology and startup support organization affiliated with Technical University of Munich. Provides resources and connections for technical startups in healthcare.

6AI Munich
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Munich-based AI innovation network supporting AI companies in the region. Partnership supports cureVision's AI development initiatives.

curevision.de
Strategic tierCoreTypeStrategic or Co-development Partner
Description

German federal government ministry providing funding and support for innovative technology companies. Supports cureVision's development of medical technology solutions.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic partnership providing research collaboration and access to talent. HM alumni successfully developed cureVision with AI-powered wound analysis.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Chemistry and healthcare innovation platform connecting startups with industry partners. cureVision featured as revolutionary wound documentation solution.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Health tech accelerator and support organization. Part of cureVision's partner ecosystem for growth and scaling.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

MolecuLight's i:X and DX fluorescence imaging devices detect bacterial load in wounds, directly mirroring cureVision's BacteriaScan capability. Both sell point-of-care imaging hardware to wound care clinicians for infection detection.

TypeEmerging player
Description

Healthy.io applies smartphone-based computer vision to clinical diagnostics (kidney disease, wound care). Its wound offering and smartphone imaging approach make it a partial overlap with cureVision's AI wound assessment strategy.

TypeBroad incumbent
Description

Smith & Nephew's Global Wound Care division sells advanced wound dressings and adjunctive digital wound management tools to the same hospitals and home care channels that cureVision targets. It is a broad incumbent rather than a niche specialist.

TypeDirect peer
Description

Swift Medical (Swift Skin and Wound) is a direct competitor offering AI-powered wound imaging and measurement for clinicians. Both companies target the same nurse and wound-care workflow with smartphone or device-based automated wound assessment.

TypeDirect peer
Description

Tissue Analytics, now part of Net Health, offers a digital wound care platform with AI-driven imaging and EHR integration. It competes directly with cureVision Web and cureVision Connect in hospital and post-acute wound documentation.

TypeDirect peer
Description

Aranz Medical's Silhouette system is a regulated 3D wound measurement and documentation device used in clinical trials and wound care clinics. It is directly comparable to cv.MESH in offering validated 3D wound measurement for healthcare providers.

TypeDirect peer
Description

WoundZoom provides tablet-based digital wound measurement and documentation for hospitals and long-term care facilities, overlapping with cureVision's hospital and nursing home target segments.

TypeBroad incumbent
Description

Mölnlycke is a major global wound care and surgical solutions company with Mepilex and other wound products. Its bundled dressing-plus-digital strategy and existing hospital relationships make it a broad incumbent that could expand into wound imaging.

TypeBroad incumbent
Description

Net Health is a specialized EHR and analytics provider for wound care, physical therapy, and occupational health. Through Tissue Analytics it offers digital wound imaging that competes with cureVision, and its broader specialty EHR suite makes it an incumbent in the same customer base.

TypeDirect peer
Description

eKare provides AI-based 3D wound measurement and tissue analysis (eKare Insight) with iPad-based hardware. It is one of the closest direct peers to cureVision in AI-driven wound documentation and analytics.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers11 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration6 records

Each record includes

Title, Type, Description, Source

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

cureVision

Medical Imaging and Wound Care Softwarecurevision.de

cureVision develops an AI-driven, MDR-certified 3D wound analysis medical device (cv.MESH) that automates chronic wound documentation for hospitals, nursing homes, and home care providers in Germany, with active U.S. expansion via BioLab Holdings.

What cureVision does

cureVision GmbH is a German health technology company founded in 2021 in Munich and Potsdam that develops an AI-driven, MDR-certified medical device system for chronic wound documentation and analysis. The core product, the cv.MESH device, combines multiple sensors — RGB camera, depth sensor, thermal imaging, and multispectral fluorescence imaging — to perform contactless, automated 3D wound measurement and tissue composition analysis in approximately two minutes per documentation, compared with roughly 20 minutes using conventional paper-ruler methods. The platform includes three subscription tiers (ESSENTIAL, PROFESSIONAL, PREMIUM), optional modules (BacteriaScan for bacterial contamination detection, ThermoScan for thermal abnormality detection, prescription recommendation), a web-based management platform (cureVision Web), and a hospital integration layer (cureVision Connect) supporting FHIR, HL7, GDT, and REST protocols.

The company sells primarily to hospitals and clinics, nursing homes and outpatient care services, and home care and wound management providers in the DACH region, with a stated go-to-market that combines direct enterprise sales, inside sales/demo booking, channel partners (notably BioLab Holdings for U.S. market entry announced in September 2025), event participation at wound fairs, and content marketing through whitepapers and case studies. Named customers include Klinikum Nürnberg, Spörer AG, Bürgerspital Landau, AGM Müller, Wundversorgung Otto, PROLIFE, PHV, Pflegedienst Engel vonne Ruhr, Sozialstation Herbert Hildebrand, Pflegeteam Geisel, and Noracare. The company is GDPR-compliant with data stored exclusively on German servers, has been recognized with multiple innovation awards (Innovationspreis Bayern 2024, Health-i Award 2023, Digitaler Gesundheitspreis 2023, Eugen Münch Preis 2023, German Startup and Digitalization Prize 2022), and has raised approximately $2.9M+ across funding rounds from 2021 through 2024 with a strategic investment from BioLab Holdings in 2025 to support U.S. market expansion, FDA clearance pursuit, and commercialization.

cureVision firmographics

Firmographics
Name
cureVision
Legal name
cureVision GmbH
Website
https://curevision.de
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Short description
cureVision develops an AI-driven, MDR-certified 3D wound analysis medical device (cv.MESH) that automates chronic wound documentation for hospitals, nursing homes, and home care providers in Germany, with active U.S. expansion via BioLab Holdings.
Ownership category
akta.pro rank

cureVision industry classification

Industry
Product category
Medical Imaging and Wound Care Software
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAKACAN
Wound Care & Ulcer Management
SECONDARYHLAKAGAK
Wound Care & Diabetic Foot Infection
SECONDARYHLADAFAH
Home-Based Wound Care & Ostomy Nursing
Healthcare & Life Sciences/Elder Care & Long-Term Care/Home Health Care Services (Skilled)
SECONDARYHLADADAJ
Complex Wound Care SNFs
Healthcare & Life Sciences/Elder Care & Long-Term Care/Skilled Nursing Facilities (SNF) & Nursing Homes
SECONDARYHLAHACAK
Continuous Temperature & Fever Monitoring (Wearable Thermometry)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics

Keywords

  • AI wound analysis
  • 3D wound measurement
  • Wound documentation software
  • Medical imaging AI
  • Chronic wound care

Where cureVision is headquartered

Location

Headquarters

HQ city
Munich
HQ country
Germany
HQ region
Europe

Offices2 records

Markets served

cureVision business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations

Revenue model

  1. Software Subscription (Tiered): Three-tier subscription model: ESSENTIAL (up to 10 patients), PROFESSIONAL (unlimited patients with telephone support), and PREMIUM (large facilities with advanced features). All tiers include base wound analysis features with optional add-ons like BacteriaScan and prescription recommendation. Plus one-time setup fee.
  2. Hardware Device Sales: Sale of cv.MESH hardware device - MDR-certified wound analysis device. Hardware is required to use the software platform. Sold as part of initial system setup.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyUp to 10 patients, essential wound documentation features
SubscriptionMonthlyUnlimited patients, telephone support, secure report sharing, editing from any device
SubscriptionMonthlyLarge teams, full customization, internal quality control, location management, FHIR integration

Go-to-market motion4 records

Distribution channels4 records

Marketing channels9 records

cureVision product offering

Product offering

Core offering

cureVision develops and sells an MDR-certified AI-driven 3D wound analysis system consisting of the cv.MESH handheld multi-sensor hardware device (RGB camera, depth sensor, thermal camera, multispectral imaging) and cloud-based software for fully automated wound measurement, tissue analysis, bacterial detection, and digital wound documentation. The solution is offered to hospitals, nursing homes, and home care providers under tiered monthly subscriptions with optional add-on modules (BacteriaScan, ThermoScan, prescription recommendation) and a one-time setup fee.

Product overview

cureVision offers a unified medical device ecosystem for AI-driven wound analysis and digital documentation, centered on the cureVision® System (cv.MESH) — an MDR-approved handheld device that performs fully automated 3D wound assessment combining RGB imaging, infrared thermography (ThermoScan), and multispectral bacterial fluorescence detection (BacteriaScan). The core system is augmented by two cloud/web components: cureVision® Web provides a PC-based platform for centralized wound report management, editing, approval workflows, and multi-location administration; and cureVision Connect enables KIS/HIS integration via FHIR or GDT protocols. Three subscription tiers (ESSENTIAL, PROFESSIONAL, PREMIUM) provide escalating access to features including the optional Prescription Recommendation module. The company also recently announced a strategic partnership with BioLab Holdings to enter the U.S. market.

Differentiator

Problem solved

Functional benefit

Brands

  • BacteriaScan: AI-powered bacterial contamination detection feature using fluorescence imaging to identify areas with increased bacterial load in wounds
  • ThermoScan
  • cureVision Web
  • cureVision Connect

Products and services

  • cureVision® System (cv.MESH) The primary MDR-approved medical device for automated 3D wound analysis. Combines multiple sensors (RGB camera, depth sensor, thermal camera, multispectral imaging) with AI to analyze wound size, depth, tissue types, temperature, and bacterial load at the push of a button. Disinfectable, fall-proof hardware that performs contact-free analysis 10x faster than manual methods, reducing documentation time from ~20 minutes to ~2 minutes. Sold to hospitals, nursing homes, and home care providers as part of the initial system setup.
  • cureVision® BacteriaScan Multispectral imaging module that detects bacterial contamination in and around wounds using violet LED-induced fluorescence to highlight porphyrin and pyoverdin metabolites. Visualizes bacterial load in red or green fluorescence, enabling early infection detection, targeted swab collection, and optimized wound cleansing. Detects bacterial loads from approximately 10^4 CFU/g and works in daylight conditions without full room darkening. Available as an add-on on the PROFESSIONAL and PREMIUM tiers.
  • cureVision® ThermoScan Infrared thermography module integrated into the cv.MESH device for early detection of abnormal thermal patterns indicating inflammation (positive temperature gradient), ischemia, or necrosis (negative temperature gradient). Generates thermal images within seconds to track wound healing progress and predict pressure ulcer development before tissue damage becomes visible on intact skin.
  • cureVision® Web Web-based platform for managing wound reports, editing documentation on PC, and administering the cureVision system. Enables centralized patient data management, digital patient file maintenance, dashboard views of wound healing progress, calendar tracking for due documentation, role-based approval workflows for quality control, multi-location management, customizable assessment questionnaires, and secure sharing of wound reports with healthcare providers.
  • cureVision Connect Interface module enabling integration of the cureVision system into hospital information systems (KIS/HIS) via FHIR, HL7, REST, or GDT (Geräte-Datenträger-Transfer) protocols. Allows wound reports to be transferred directly into patient files automatically. Existing interfaces available with acriba and HalloAlberta industry software. Available on the PREMIUM tier for an additional charge, with FHIR integration priced by individual agreement.

Quantifiable outcome

  • 90% time reduction in wound documentation (from 20 minutes to 2 minutes)
  • +3 more outcomes

Companies that use cureVision

Customer profile

Named customers11 records

Segments3 records

Ideal customer profiles3 records

cureVision technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability8 records

Feature8 records

cureVision partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core and minor.

  • BioLab HoldingscoreStrategic or Co-development Partner · 4 September 2025Strategic investment and partnership to introduce cureVision's AI-driven wound assessment technology in the U.S. market. BioLab provides distribution network, regulatory approval support, reimbursement expertise, and commercialization capabilities. Aimed at accelerating cureVision's FDA approval and market entry in the United States.
  • Strascheg Center for Entrepreneurship (SCE)coreStrategic or Co-development PartnerSupported cureVision from early stages. Recognized company's potential and provided support through startup incubation program. CureVision won multiple awards through SCE connections including Health-i-Award 2023.
  • EIT HealthcoreStrategic or Co-development PartnerEuropean Institute of Innovation and Technology Health program recognized cureVision's potential and provided support. Part of innovation ecosystem helping healthcare startups scale.
  • Angels4HealthcoreStrategic or Co-development PartnerHealthcare innovation network that recognized cureVision's potential and provided backing. Supports company on mission to improve treatment and quality of life for chronic wound patients.
  • TUM Venture LabsminorStrategic or Co-development PartnerTechnology and startup support organization affiliated with Technical University of Munich. Provides resources and connections for technical startups in healthcare.
  • AI MunichminorStrategic or Co-development PartnerMunich-based AI innovation network supporting AI companies in the region. Partnership supports cureVision's AI development initiatives.
  • Federal Ministry for Economic Affairs (Bundesministerium für Wirtschaft)coreStrategic or Co-development PartnerGerman federal government ministry providing funding and support for innovative technology companies. Supports cureVision's development of medical technology solutions.
  • Munich University of Applied Sciences (Hochschule München)minorStrategic or Co-development PartnerAcademic partnership providing research collaboration and access to talent. HM alumni successfully developed cureVision with AI-powered wound analysis.
  • 5-HT Chemistry & HealthminorStrategic or Co-development PartnerChemistry and healthcare innovation platform connecting startups with industry partners. cureVision featured as revolutionary wound documentation solution.
  • LuminateminorStrategic or Co-development PartnerHealth tech accelerator and support organization. Part of cureVision's partner ecosystem for growth and scaling.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

cureVision competitors and assessment

Company assessment

Direct peers

  • MolecuLight: MolecuLight's i:X and DX fluorescence imaging devices detect bacterial load in wounds, directly mirroring cureVision's BacteriaScan capability. Both sell point-of-care imaging hardware to wound care clinicians for infection detection.
  • Swift Medical: Swift Medical (Swift Skin and Wound) is a direct competitor offering AI-powered wound imaging and measurement for clinicians. Both companies target the same nurse and wound-care workflow with smartphone or device-based automated wound assessment.
  • Tissue Analytics (a Net Health company): Tissue Analytics, now part of Net Health, offers a digital wound care platform with AI-driven imaging and EHR integration. It competes directly with cureVision Web and cureVision Connect in hospital and post-acute wound documentation.
  • Aranz Medical (Silhouette): Aranz Medical's Silhouette system is a regulated 3D wound measurement and documentation device used in clinical trials and wound care clinics. It is directly comparable to cv.MESH in offering validated 3D wound measurement for healthcare providers.
  • WoundZoom: WoundZoom provides tablet-based digital wound measurement and documentation for hospitals and long-term care facilities, overlapping with cureVision's hospital and nursing home target segments.
  • eKare Inc. eKare provides AI-based 3D wound measurement and tissue analysis (eKare Insight) with iPad-based hardware. It is one of the closest direct peers to cureVision in AI-driven wound documentation and analytics.

Emerging players

  • Healthy.io: Healthy.io applies smartphone-based computer vision to clinical diagnostics (kidney disease, wound care). Its wound offering and smartphone imaging approach make it a partial overlap with cureVision's AI wound assessment strategy.

Broad incumbents

  • Smith & Nephew: Smith & Nephew's Global Wound Care division sells advanced wound dressings and adjunctive digital wound management tools to the same hospitals and home care channels that cureVision targets. It is a broad incumbent rather than a niche specialist.
  • Mölnlycke Health Care: Mölnlycke is a major global wound care and surgical solutions company with Mepilex and other wound products. Its bundled dressing-plus-digital strategy and existing hospital relationships make it a broad incumbent that could expand into wound imaging.
  • Net Health (Tissue Analytics parent): Net Health is a specialized EHR and analytics provider for wound care, physical therapy, and occupational health. Through Tissue Analytics it offers digital wound imaging that competes with cureVision, and its broader specialty EHR suite makes it an incumbent in the same customer base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

cureVision social profiles

Digital presence

cureVision compliance and trust

Trust signal

Compliance3 records

cureVision financial estimates

Financial estimate

Revenue estimate

Valuation estimate

cureVision leadership team

Management profile

Number of profiles

Profiles3 records

cureVision funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

cureVision M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about cureVision

What does cureVision do?

cureVision develops and sells an MDR-certified AI-driven 3D wound analysis system consisting of the cv.MESH handheld multi-sensor hardware device (RGB camera, depth sensor, thermal camera, multispectral imaging) and cloud-based software for fully automated wound measurement, tissue analysis, bacterial detection, and digital wound documentation. The solution is offered to hospitals, nursing homes, and home care providers under tiered monthly subscriptions with optional add-on modules (BacteriaScan, ThermoScan, prescription recommendation) and a one-time setup fee.

Is cureVision a public or private company?

cureVision is a private company. It is classified as venture growth investor backed and is currently operating.

When was cureVision founded?

cureVision was founded in 2021. It employs 11 to 50 people.

Where is cureVision based?

cureVision is headquartered in Munich, Germany, in the Europe region.

How does cureVision make money?

Two revenue lines are on record. Software Subscription (Tiered) is the primary driver. The others are hardware Device Sales.

Who are cureVision's main competitors?

Direct peers on record are MolecuLight, Swift Medical, Tissue Analytics (a Net Health company), Aranz Medical (Silhouette), WoundZoom and eKare Inc.. Healthy.io is listed as an emerging player. Broad incumbents are Smith & Nephew, Mölnlycke Health Care and Net Health (Tissue Analytics parent).

Does cureVision have an API?

Yes. cureVision offers integration via established standards including HL7, HL7 FHIR, and REST. Existing interfaces exist in industry software such as acriba and Hallo Alberta. cureVision Connect enables integration into hospital information systems (KIS/HIS) via FHIR or GDT (Geräte-Datenträger-Transfer) protocols. Integration is priced by individual agreement for an additional charge on the PREMIUM tier.

What industry is cureVision in?

cureVision's product category is Medical Imaging and Wound Care Software. Its primary akta.pro industry code is HLAKACAN, Wound Care & Ulcer Management, with a secondary code of HLAKAGAK, Wound Care & Diabetic Foot Infection. Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
F6s100 Top Medical Network Companies · November 2025F6S published its list of the 100 top Medical Network companies and startups for November 2025, tracking entities within the Healthcare industry. The report highlights a diverse range of innovators, including cureVision, Medcol AI, and EqualityMD, covering sectors from AI diagnostics to LGBTQ+ inclusive care. This snapshot serves as a directory of emerging players in the global medical technology and service landscape.StartbasecureVision continues to scalecureVision, a Potsdam-based medical technology startup specializing in AI-supported medical imaging, has successfully completed a financing round with investments from Companisto Business Angel Network, Brandenburg Kapital, BioLab Holdings Inc., and other co-investors. The company intends to use the funds to further develop its AI technology for automated 3D wound measurement with integrated bacterial scanning, expand its sales operations, and prepare for entry into the US market in 2026. cureVision has also received multiple innovation awards and plans to expand its AI platform to additional clinical indications and hospital information system integrations.RbjHealthtech startup leverages AI to manage chronic woundsMunich-based cureVision developed an AI-driven wound analysis tool that measures wound dimensions and tissue types, claiming 90% faster analysis with 98% accuracy. The company plans to expand into the US market, where the chronic wound diagnosis and treatment market is projected to reach $30 billion by 2029.